
Research finds automated segmentation software examines OCT scans

Research finds automated segmentation software examines OCT scans

ICYMI: Nir Israeli, co-founder and CEO of Sanoculis discusses the company's new alternative surgical procedure for glaucoma designed to create a single-patient-use sterile tool and a multi-use external machine.

ICYMI: Chris Adams, CEO of Diopter Corp, discusses the company's drug delivery contact lens technology in the pipeline that works to treat ocular surface disease, during the 2020 Glaucoma 360 meeting in San Francisco, California.

High-level observations for how the latest developments can help glaucoma specialists solve problems to achieve the utmost in patient care

New products increase the chance of early diagnosis

Physicians can discover, diagnose, document, treat diseases that might go undetected

ICYMI: Daria Lemann Blumenthal, CEO of BELKIN Laser, Ltd., discusses the company's current initiative of developing an automated one-second laser therapy for glaucoma called direct selective laser trabeculoplasty (DSLT).

Patient expectations continue to push clinicians to look at optimal ways to arrive at the best IOLs.
















